These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Degree of anemia, indirect markers of hemolysis, and vascular complications of sickle cell disease in Africa. Dubert M; Elion J; Tolo A; Diallo DA; Diop S; Diagne I; Sanogo I; Belinga S; Guifo O; Wamba G; Ngo Sack F; Boidy K; Kamara I; Traore Y; Diakite CO; Gbonon V; Faye BF; Seck M; Deme Ly I; Chelo D; N'Guetta R; Diop IB; Gaye B; Jouven X; Ranque B Blood; 2017 Nov; 130(20):2215-2223. PubMed ID: 28931524 [TBL] [Abstract][Full Text] [Related]
27. [The sickle cell anemia lung from childhood to adulthood]. Fauroux B; Muller MH; Quinet B; Bégué P Rev Mal Respir; 1998 Apr; 15(2):159-68. PubMed ID: 9608986 [TBL] [Abstract][Full Text] [Related]
28. Hemopexin therapy improves cardiovascular function by preventing heme-induced endothelial toxicity in mouse models of hemolytic diseases. Vinchi F; De Franceschi L; Ghigo A; Townes T; Cimino J; Silengo L; Hirsch E; Altruda F; Tolosano E Circulation; 2013 Mar; 127(12):1317-29. PubMed ID: 23446829 [TBL] [Abstract][Full Text] [Related]
29. Pulmonary hypertension: an increasingly recognized complication of hereditary hemolytic anemias and HIV infection. Barnett CF; Hsue PY; Machado RF JAMA; 2008 Jan; 299(3):324-31. PubMed ID: 18212317 [TBL] [Abstract][Full Text] [Related]
30. Sickle cell anemia and related hemoglobinopathies. Vichinsky EP; Lubin BH Pediatr Clin North Am; 1980 May; 27(2):429-47. PubMed ID: 6155657 [TBL] [Abstract][Full Text] [Related]
31. Pulmonary complications of sickle cell disease in adults. Ardiles T; Dark D Mo Med; 2007; 104(3):250-4. PubMed ID: 17619501 [TBL] [Abstract][Full Text] [Related]
32. Mutations and polymorphisms in hemoglobin genes and the risk of pulmonary hypertension and death in sickle cell disease. Taylor JG; Ackah D; Cobb C; Orr N; Percy MJ; Sachdev V; Machado R; Castro O; Kato GJ; Chanock SJ; Gladwin MT Am J Hematol; 2008 Jan; 83(1):6-14. PubMed ID: 17724704 [TBL] [Abstract][Full Text] [Related]
33. Vasculopathy in sickle cell disease: Biology, pathophysiology, genetics, translational medicine, and new research directions. Kato GJ; Hebbel RP; Steinberg MH; Gladwin MT Am J Hematol; 2009 Sep; 84(9):618-25. PubMed ID: 19610078 [TBL] [Abstract][Full Text] [Related]
34. Acute hemolytic vascular inflammatory processes are prevented by nitric oxide replacement or a single dose of hydroxyurea. Almeida CB; Souza LE; Leonardo FC; Costa FT; Werneck CC; Covas DT; Costa FF; Conran N Blood; 2015 Aug; 126(6):711-20. PubMed ID: 26019278 [TBL] [Abstract][Full Text] [Related]
35. Low micromolar intravascular cell-free hemoglobin concentration affects vascular NO bioavailability in sickle cell disease: a computational analysis. Deonikar P; Kavdia M J Appl Physiol (1985); 2012 Apr; 112(8):1383-92. PubMed ID: 22223452 [TBL] [Abstract][Full Text] [Related]
36. Pulmonary hypertension in a case of Hb-Mainz hemolytic anemia. Lode HN; Krings G; Schulze-Neick I; Dähmlow S; Schroeder U; Bonnet R; DaPalma J; Luck W; Strauss G; Berger F; Gaedicke G J Pediatr Hematol Oncol; 2007 Mar; 29(3):173-7. PubMed ID: 17356397 [TBL] [Abstract][Full Text] [Related]
37. Pulmonary hypertension and nitric oxide depletion in sickle cell disease. Bunn HF; Nathan DG; Dover GJ; Hebbel RP; Platt OS; Rosse WF; Ware RE Blood; 2010 Aug; 116(5):687-92. PubMed ID: 20395414 [TBL] [Abstract][Full Text] [Related]